The UW/FHCRC Center for AIDS Research Developmental Core announces the availability of funds to support New Investigator Awards (NIAs) in the area of human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS) related research.
An electronic version of this RFA is available here [135K, DOC]. 
The purpose of this award program is to encourage junior investigators (at a senior stage of training or recently independent) to conduct independent research, acquire preliminary date to use for exogenous grant submissions, receive mentorship, and write one or more grants to obtain funding to continue their HIV/AIDS research careers.
(1) Current UW junior faculty (including acting positions) who have not had an R01 grant in HIV/AIDS
(2) Scientists completing fellowships
(3) Senior post-doctoral fellows initiating a new area of research that will form a basis for their independent program
(4) Junior faculty being recruited to the UW faculty or affiliated institutions
(5) Investigators with comparable appointments at UW-affiliated institutions (e.g., Fred Hutchinson Cancer Research Center, Seattle Biomed, Seattle Children’s, and affiliated international institutions)
(6) Investigators at the University of Hawaii with comparable positions
Note that applicants are required to have an MD or PhD or equivalent terminal degree in order to be eligible to apply. NIH K awards do not impact on eligibility as long as the requested funds support different items. (The research can be on the same topic.) Successful applicants usually have some preliminary data to support their application. Resubmission of revised projects by previous applicants that address critiques of prior proposal is allowed (see application instructions).
HIV-related research is defined broadly and includes basic science, clinical, epidemiological, and behavioral, and health services research. We encourage applications in the field of implementation science, which is one of the new CFAR Scientific Working Groups.
Per NIH, we cannot fund clinical trials of investigational drugs. If you are considering a study involving approved drugs and/or standard-of-care, please contact Ann Collier (firstname.lastname@example.org , cc: email@example.com ; 206-744-3293) to determine whether your proposed project would be eligible for funding through CFAR.
Awards will be up to $45,000/year (direct costs) for non-interdisciplinary applications or up to $55,000 (direct costs) for interdisciplinary projects. Applicants may apply for up to 2 years of funding. The CFAR does not have funds to cover additional indirect costs and has negotiated indirect cost waivers with several local institutions.
The award can be used for salary, technical support, laboratory supplies, equipment, and travel costs related to the project. Be sure to read our Computer Policy  if you would like to budget for a computer.
Requests for Second Year of Funding: Second year funding is contingent upon demonstration of satisfactory progress during year one.
Required for All Applicants
Biostatistical Consultation: All applicants are required to discuss their proposal with one of CFAR’s biostatisticians prior to/during the preparation of their application, with limited exceptions for those with prior biostatistical involvement or review of their projects. This consultation is best done early in the preparation process but must occur before July 3, 2013. If you are a local investigator, please contact Lauren Sterling (firstname.lastname@example.org  or 206-744-8876) to schedule your biostatistical review before June 26, 2013. There will be a limited number of time slots available for you to schedule your in-person consultation. You will be required to submit a draft of your methods 48 hours before your consultation. If you are an international investigator, please send a copy of your draft methods to Lauren Sterling (email@example.com ), and she will arrange your written consultation with a CFAR biostatistician.
CFAR Membership: All applicants are required to be UW/FHCRC CFAR Members. Information about membership can be found at http://depts.washington.edu/cfar/get-involved/cfar-membership  or by contacting Michelle Ward (firstname.lastname@example.org ).
Required for Some Applicants
International Applicants: International applicants must obtain approval that they are eligible to apply prior to development of their proposal. They should send a current NIH format biosketch or curriculum vitae for review to Lauren Sterling (email@example.com ; cc: firstname.lastname@example.org ) no later than June 26, 2013.
Institutional Approval for non-UW Applicants: Applicants from other institutions should prepare and submit a NIH 398 face page, with concurrence from their institution’s business official. UW applicants do not need departmental, school, or Office of Sponsored Programs signatures. Please note that the CFAR does not have funds to cover additional institutional indirect costs and has negotiated indirect cost waivers from Fred Hutchinson Cancer Research Center and Seattle Children’s. For more information, contact Lauren Sterling (email@example.com ; 206-744-8876) prior to the development of their proposal and no later than July 12, 2013.
Administrative Consultation: Applicants from all (including UW) institutions are strongly encouraged to consult with the Program Manager about their budgets to clarify budgetary issues. Please send a draft copy of your budget and justification to Lauren Sterling at firstname.lastname@example.org  no later than July 12, 2013.
Interdisciplinary Proposals: Multidisciplinary projects are encouraged and are defined as involving 2 or more investigators that have differing areas of expertise or different research focuses, e.g. applicant and a co-investigator with differing areas of expertise or applicant plus 1-2 co-mentors with at least one of the co-mentors having different expertise than the applicant (at least one mentor must be faculty at UW or a UW affiliated institution). On the cover page, the applicant must provide a rationale as to why the applicant considers the project to be interdisciplinary.
Mentoring: It is strongly recommended that applicants identify a mentor while preparing their application. If needed, please contact Dr. Collier to provide suggestions for possible mentors. A statement from the applicant’s primary mentor that they have read and discussed the application with the applicant must accompany the application (should be included in the letter of support from the mentor). Please note that a Mentoring Committee will be formed for successful applicants to provide guidance for their career development and to assess progress of each NIA awardee at least annually.
Human Subjects and Animal Care Approvals: Animal Care and Institutional Review Board approvals, if applicable, must be obtained prior to receipt of award funding, but are not required to submit an application.
Use of CFAR Resources: We encourage all applicants to use or contact CFAR Cores or link to CFAR Scientific Working Groups. Several cores and the Implementation Science Working Group have explicitly offered their consultations services (see Core Consultation Information below). Information about other CFAR cores and services can be found at http://depts.washington.edu/cfar/find-a-service .
These consultations are best done early in the preparation process but no later than July 3, 2013.
International Study Consultation: International applicants have the option of receiving an International Core Consultation, to help evaluate their study design. In order to receive this consultation, applicants must email a draft of their application to email@example.com .
Sociobehavioral Study Consultation: Sociobehavioral applicants have the opportunity to have an expert from the Sociobehavioral and Prevention Research Core consult with them regarding their study design. In order to receive this consultation, applicants must email a draft of their application to firstname.lastname@example.org .
Clinical Research Study Consultation: Those proposing clinical, translational or basic research projects that require access to local research subjects, clinical specimens/procedures or viral assays such as droplet PCR, 2LTR, single copy RNA tests and proviral DNA measurements may contact the Clinical and Retrovirology Research Core to discuss their proposal. Applicants should contact the Core Manager Michalina Montano (email@example.com ) with a short description of the study and necessary access for assistance.
Immunological Study Consultation: Applicants proposing an immunology or other appropriate basic research study study have the opportunity to have an expert from the Immunology Core consult with them regarding their experimental design. In order to receive this consultation, applicants should contact Stephen De Rosa at firstname.lastname@example.org .
Implementation Science Study Consultation: Applicants proposing a study in the field of implementation science have the opportunity to have an expert from the Implementation Science Working Group consult with them regarding their study. In order to receive this consultation, applicants should contact Kenny Sherr at email@example.com .
Human Subjects and Animal Care Approvals: Prior to funding, a copy of all Institutional Biohazard, Animal Care and IRB approvals must be forwarded to the CFAR Program Manager. If the project involves human subjects and the institutional IRB has deemed the study “greater than minimal risk”, the awardee must submit a Clinical Research Checklist to the CFAR Program Manager before funding is released. Proposals involving either international sites or clinical research above minimal risk will require additional clearance from NIH prior to receipt of an award, which includes IRB approval from all participating sites and human subjects training certification for all key personnel. It is recommended that if your study is minimal risk or below and linked to a non-minimal risk study, you apply for independent approval by the UW IRB – this will expedite the regulatory approval process.
Mentoring Committee and Agreement: Awardees will draw up a brief written agreement with their mentor and identify members of the mentoring committee.
Reporting and Presentation Requirements: Awardees will be required to submit yearly progress reports to the CFAR and make an oral presentation at the annual UW AIDS & STD Research Symposium. The chair of the mentoring committee will also be required to submit a brief progress report annually before Year 2 funding can be received.
CFAR Support: CFAR support (P30 AI027757) must be acknowledged in all publications and presentations derived from CFAR funding (see: http://depts.washington.edu/cfar/discover-cfar/acknowledge-cfar ).
Other Support: In the event that pending other support is funded which overlaps with or reduces your effort on this CFAR project, you must notify the CFAR Program Manager. Your funding status will be reviewed and if it is determined that you are unable to meet the specific aims of your CFAR proposal, the CFAR award will be revoked.
Post-Award Requirements: After project is completed, awardees need to agree to provide contact information and respond to annual queries about publications, collaborations and future grants related to the CFAR project.
After completing all pre-submission requirements, submit the following in one PDF (preferred) or MS Word file by 9:00 a.m. PDT July 15, 2013 to https://depts.washington.edu/cfar/find-funding/new-investigator-awards/submission-form . Please note that there are several questions on the submission form that you will need to answer in order to submit your application. They are listed below the proposal information so that you can prepare your answers ahead of time.
The full proposal will be on PHS 398 forms  and should follow a modified NIH investigator initiated grant application (R01) format (For more resources see: http://www.niaid.nih.gov/ncn/grants/app/default.htm ) with the modifications listed below). The Research Plan (Specific Aims through Approach) is limited to 4 pages (Bibliography and References Cited sections do not count toward the page limit). No appendices are allowed. Do not submit Targeted/Planned Enrollment Tables. Submit a detailed budget, not a modular budget.
- Face Page: (PHS 398 Form page 1 - Download: MS Word  or PDF ) Institutional sign-off for Non-UW applicants required.
- Project Summary Page: (PHS 398 Form page 2 - Download: MS Word  or PDF )
- Detailed budget for 12 month period: (PHS 398 Form page 4 - Download: MS Word  or PDF )
- Complete budget and justification: (PHS 398 Form page 5 - Download: MS Word  or PDF )
- Resources page (PHS 398 Format - Download: MS Word  or PDF ; maximum length 1 page)
- Biographical Sketch for the NIA applicant (PHS 398 Format - Download: MS Word  or PDF )
- Biographical Sketch for NIA mentor only (PHS 398 Format - Download: MS Word  or PDF )
- Research Plan (Maximum 4 pages for a-d below). Use PHS 398 Continuation Format pages (Download: MS Word  or PDF ).
- Specific Aims (suggested length ½ page)
- Significance (suggested length 1 page)
- Innovation (suggested length ½ page)
- Approach (suggested length 2 pages)
- Bibliography and References cited (as needed)
- Protection of Human Subjects (if applicable; maximum 1 page)
- Vertebrate Animals (if applicable; maximum 1 page)
- Mentor’s Letter of Support (should include the statement “I have read and discussed this application with _____ and am supportive of its submission.”)
- Letters of support (Only allowed from collaborators essential to the proposed project. Biosketches are not required for collaborators.)
Additional Information Requested in the Online Submission Form:
How will the CFAR NIA prepare you for a career as an independent HIV/AIDS investigator?
Topic Key Words (5-10)
Justification for Interdisciplinary Award (if applicable)
Suggested Reviewers (2 non-Seattle, non-conflicted investigators required)
- Previous application title and date submitted
- Major changes from the prior application
- Your response to the reviewer’s comments from your prior submission
- Any other information relevant to the resubmission
- Requested support for project collaborators who are NOT at the same institution as the awardee should be listed as consultant costs. If the collaborator cannot accept consultancy fees, a subcontract must be issued to their institution. These costs must be listed in the detailed budget as consortium costs with applicable indirect costs included.
- Requested support for equipment and technology, including computers, must be fully justified in the budget justification with a clear connection to the scientific aspects of the project and not for general office use. Be sure to read our Computer Policy  if you would like to budget for a computer.
- Tuition, fees and stipends for graduate students are allowable within the following guidelines:
- Total compensation (salary, fringe, and tuition/fees) cannot exceed $37,740. (NOT-OD-10-047)
- Costs associated with Institutional Review Board (IRB) review of human research protocols, or Institutional Animal Care and Use Committee (IACUC) review of animal research protocols, are not allowable as direct charges.
- All costs must conform to the NIH Grants Policy Statement (GPS) and applicable U.S. Office of Management and Budget OMB circulars for necessity and reasonability, allocability, conformance and consistency, as well as allowability. Please follow the link below to section 7.2 cost principles section of the NIH Grants Policy Statement .
The evaluation criteria for proposals include:
- Scientific Merit of the proposal and the likelihood of the project to exert a sustained powerful influence on the field. Will this proposal be likely to provide information that can significantly advance our understanding of HIV and/or provide preliminary data that is likely to lead towards independent research grant funding?
- Significance – Does the study address an important problem consistent with the objective to advance our understanding of HIV? If the aims are achieved, how will scientific knowledge be advanced? What will be the effect of these studies on the concepts or methods that drive the field of HIV and AIDS?
- Investigator – Are the PI, mentor(s), collaborators, and other researchers well suited to the project? Does this person have appropriate experience and training? If the project is collaborative, do the investigators/mentors have complementary expertise?
- Approach – Are the conceptual framework, design methods, and analyses adequately developed, well integrated and appropriate to the aims of the project? Does the applicant acknowledge potential problem areas and consider alternatives?
- Innovation – Does the project employ novel concepts, approaches, or methods? Are the aims original and innovative? Does the project challenge existing paradigms or develop new methodologies or technologies?
- Impact of Project on Pathway to Independence – Will the project help prepare the applicant for a career as an independent HIV/AIDS researcher? Will the proposed mentorship aid in the investigator’s career development?